Molcure

A high-speed, high-quality, high-variation antibody screening & design system combining biology, automation and bioinformatics

Based based in Tokyo, Japan, Molcure works in health, founded in 2013.

Profile

"Molcure is a pioneering health company specializing in high-speed, high-quality, and high-variation antibody screening and design systems that merge biology, automation, and bioinformatics. Dedicated to enhancing patient lives, Molcure focuses on developing more effective therapeutics and supportive care products through cutting-edge antibody and target discovery. With a strong emphasis on technology, Molcure is the preferred partner for therapeutic antibody discovery, utilizing their advanced antibody discovery platform, Abtracer, to deliver superior functional antibodies. Their expertise in next-generation sequencing, bioinformatics, and antibody biology, combined with automated discovery systems, has been validated through numerous successful partnerships. Molcure is actively seeking new collaboration opportunities to further advance their mission of revolutionizing antibody-based therapeutics."

Within the health space, the company focuses on its core offering rather than a broad product line.

The business is associated with Tokyo, Japan.

Its current recorded stage is Plug and Play accelerated startup.

Recorded headcount: 11-50 employees.

Website: www.molcure.com